Document is current
Any future updates will be listed below
-
Authors
Lü, Jinhui
Zhao, Qian
Guo, Yuefan
Li, Danni
Xie, Heying
Liu, Cuicui
Hu, Xin
Liu, Suling
Hou, Zhaoyuan
wei, Xunbin
Zheng, Deyou
Pestell, Richard G.
Yu, Zuoren https://orcid.org/0000-0003-4196-9662
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81972476)
- License Information
-
More Information
Article History
Received: 21 January 2023
Accepted: 7 April 2023
First Online: 20 April 2023
Declarations
:
: All the procedures on human breast tumor samples were approved by the Institutional Review Board (IRB) of Shanghai East Hospital. All patients were provided with written informed consent form. All procedures on the animal studies were approved by the Institutional Animal Care and Use Committee of the Tongji University School of Medicine.
: The authors declare that they have no relevant financial conflicts of interest. R.G.P. holds ownership interests in CytoDyn, EcoGenome, StromaGenesis and LightSeed, Inc. R.G.P. additionally holds ownership interests (value unknown) for several patents and submitted patent applications.
